Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5422-5436

  Ioannidis, Ioannis ^a   McNally, Beth ^a   Willette, Meredith ^a   Peeples, Mark E ^a,b   Chaussabel, Damien ^c   Durbin, Joan E ^d   Ramilo, Octavio ^a,b   Mejias, Asuncion ^a,b   Flaño, Emilio ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 1ALPHA; INTERLEUKIN 23; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; INTERLEUKIN 32; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; SPECIES SPECIFICITY;

MURINAE; ORTHOMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84861321791     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06757-11     Document Type: Article

References (60)

1. Bals R, Hiemstra PS. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23:327-333.
2. Bernasconi D, Amici C, La Frazia S, Ianaro A, Santoro MG. 2005. The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J. Biol. Chem. 280:24127-24134.
3. Berry MP, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977.
4. Bertrand P, Aranibar H, Castro E, Sanchez I. 2001. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr. Pulmonol. 31:284 -288.
5. Bitko V, Barik S. 1998. Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein. J. Virol. 72:5610 -5618.
6. Chaussabel D, et al. 2008. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29:150 -164.
7. Ciencewicki JM, Brighton LE, Jaspers I. 2009. Localization of type I interferon receptor limits interferon-induced TLR3 in epithelial cells. J. Interferon Cytokine Res. 29:289 -297.
8. Diamond G, Legarda D, Ryan LK. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173:27-38.
9. Dvorak A, Tilley AE, Shaykhiev R, Wang R, Crystal RG. 2011. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am. J. Respir. Cell Mol. Biol. 44:465- 473.
10. Fernandez-Sesma A, et al. 2006. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80:6295- 6304.
11. Fjaerli HO, et al. 2006. Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect. Dis. 6:175.
12. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. 2005. Well-differentiated human airway epithelial cell cultures. Methods Mol. Med. 107:183-206.
13. Girard MP, Cherian T, Pervikov Y, Kieny MP. 2005. A review of vaccine research and development: human acute respiratory infections. Vaccine 23:5708 -5724.
14. Glezen WP, Taber LH, Frank AL, Kasel JA. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
15. Goodman AG, et al. 2010. The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling. J. Virol. 84:2027-2037.
16. Hall CB, Douglas RG, Jr, Simons RL, Geiman JM. 1978. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J. Pediatr. 93:28 -32.
17. Hall CB, Walsh EE, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:693- 698.
18. Hallak LK, Spillmann D, Collins PL, Peeples ME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:10508 -10513.
19. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8:142-152.
20. Huang Q, et al. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875.
21. Humlicek AL, et al. 2007. Paracellular permeability restricts airway epithelial responses to selectively allow activation by mediators at the basolateral surface. J. Immunol. 178:6395- 6403.
22. Hussell T, Goulding J. 2010. Structured regulation of inflammation during respiratory viral infection. Lancet Infect. Dis. 10:360 -366.
23. Jenner RG, Young RA. 2005. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3:281-294.
24. Jewell NA, et al. 2010. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 84:11515-11522.
25. Jewell NA, et al. 2007. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J. Virol. 81:9790 -9800.
26. Kato A, Schleimer RP. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19:711-720.
27. Kular RK, et al. 2009. GAGE, an antiapoptotic protein binds and modulates the expression of nucleophosmin/B23 and interferon regulatory factor 1. J. Interferon Cytokine Res. 29:645- 655.
28. Labrada L, Liang XH, Zheng W, Johnston C, Levine B. 2002. Agedependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 76:11688- 11703.
29. Liu P, et al. 2007. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virusinfected airway epithelial cells. J. Virol. 81:1401-1411.
30. Lopez-Souza N, et al. 2004. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am. J. Physiol. 286:L373-L381.
31. Martinez I, Lombardia L, Garcia-Barreno B, Dominguez O, Melero JA. 2007. Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol. 88: 570-581.
32. Mizgerd JP. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358:716 -727.
33. Mordstein M, et al. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151.
34. Openshaw PJ. 2005. Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc. Am. Thorac Soc. 2:121- 125.
35. Pankla R, et al. 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10:R127.
36. Papi A, Luppi F, Franco F, Fabbri LM. 2006. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3:245-251.
37. Peebles RS, Jr, Graham BS. 2005. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc. Am. Thorac. Soc. 2:110 -115.
38. Pickles RJ, et al. 1998. Limited entry of adenovirus vectors into welldifferentiated airway epithelium is responsible for inefficient gene transfer. J. Virol. 72:6014-6023.
39. Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Diaz PV. 2006. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 117:e878-e886.
40. Qureshi F, Pestian J, Davis P, Zaritsky A. 1998. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N. Engl. J. Med. 339:1030 -1035.
41. Ramilo O, et al. 2007. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109:2066 -2077.
42. Rosebeck S, Leaman DW. 2008. Mitochondrial localization and proapoptotic effects of the interferon-inducible protein ISG12a. Apoptosis 13:562-572.
43. Rowe RK, Brody SL, Pekosz A. 2004. Differentiated cultures of primary hamster tracheal airway epithelial cells. In vitro Cell. Dev. Biol. Anim. 40:303-311.
44. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. 2007. Epithelium: at the interface of innate and adaptive immune responses. J. Allergy Clin. Immunol. 120:1279 -1284.
45. Schmid S, Mordstein M, Kochs G, Garcia-Sastre A, Tenoever BR. 2010. Transcription factor redundancy ensures induction of the antiviral state. J. Biol. Chem. 285:42013- 42022.
46. Shapira SD, et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
47. Shaykhiev R, Bals R. 2007. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J. Leukoc. Biol. 82:1-15.
48. Shornick LP, et al. 2008. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J. Immunol. 180:3319 -3328.
49. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363- 4369.
50. Taubenberger JK, Morens DM. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3:499 -522.
51. Thompson CI, Barclay WS, Zambon MC, Pickles RJ. 2006. Infection of human airway epithelium by human and avian strains of influenzaAvirus. J. Virol. 80:8060-8068.
52. Ueno K, et al. 2008. MUC1 mucin is a negative regulator of Toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 38:263-268.
53. Varga ZT, et al. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7:e1002067.
54. Wang J, et al. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J. Immunol. 182:1296 -1304.
55. Weslow-Schmidt JL, et al. 2007. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J. Virol. 81:9778 -9789.
56. Yoboua F, Martel A, Duval A, Mukawera E, Grandvaux N. 2010. Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta. J. Virol. 84:7267- 7277.
57. You Y, Richer EJ, Huang T, Brody SL. 2002. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am. J. Physiol. 283:L1315-L1321.
58. Zaas AK, et al. 2009. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6:207-217.
59. Zhang L, et al. 2005. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79:1113-1124.
60. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76:5654 -5666.